The Impacts of Different Types of Radiation on the CRT and PDL1 Expression in Tumor Cells Under Normoxia and Hypoxia

被引:14
|
作者
Huang, Yangle [1 ,2 ]
Huang, Qingting [1 ,2 ]
Zhao, Jingfang [2 ,3 ]
Dong, Yuanli [1 ,2 ]
Zhang, Lijia [2 ,3 ]
Fang, Xumeng [1 ,2 ]
Sun, Pian [1 ,2 ]
Kong, Lin [1 ,2 ]
Lu, Jiade Jay [1 ,2 ]
机构
[1] Fudan Univ, Shanghai Proton & Heavy Ion Ctr, Dept Radiat Oncol, Canc Hosp, Shanghai, Peoples R China
[2] Shanghai Engn Res Ctr Proton & Heavy Ion Radiat T, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Proton & Heavy Ion Ctr, Dept Med Phys, Canc Hosp, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
proton radiation; carbon-ion radiation; normoxia; hypoxia; calreticulin; PDL1; CARBON ION; RESISTANCE; IRRADIATION; OVERCOME; STRESS; HEAD;
D O I
10.3389/fonc.2020.01610
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Hypoxia is a hallmark of cancer that may contribute to an immunosuppressive microenvironment and promote radioresistance. High linear energy transfer (LET) radiation is considered to be able to overcome the negative effects of hypoxia. However, the anti-tumorigenic effects induced by low or high LET radiation have not been fully elucidated. This study aimed to compare the effects of different types of radiation on the immune response, particularly the impact on calreticulin (CRT), and programmed cell death ligand 1 (PDL1) expression. Methods Four human tumor cell lines were investigated in this study. Cells in normoxic and hypoxic groups were irradiated with 4Gy (physical dose) photon, proton, and carbon-ion radiation, respectively. The expression of CRT and PDL1 was detected 48 h after irradiation, and the median fluorescence intensities (MFIs) were compared by flow cytometry. Meanwhile, the radiosensitivity of tumor cells in each group was also compared by colony formation assays and flow cytometry. Results All types of radiation could significantly inhibit the colony formation of tumor cells under normoxia. However, the efficacy of photon and proton radiation was impaired under hypoxia. Carbon-ion radiation could still inhibit colony formation. The percentage of viable cells after irradiation was higher under hypoxia compared with those under normoxia. The CRT expression under normoxia was significantly increased after radiation. Carbon-ion radiation enhanced CRT expression compared to photon and proton radiation. Conversely, under hypoxia, the CRT expression level was significantly upregulated at baseline (0Gy). Radiation could not increase the expression further. PDL1 expression was also significantly increased by radiation under normoxia in all cell lines except the Ln18 cell line. Carbon-ion radiation induced the most significant increase. Under hypoxia, the PDL1 expression level was also upregulated at baseline and radiation could not increase expression further. Conclusion Tumor cells were resistant to photon and proton but sensitive to carbon-ion radiation under hypoxia. Carbon-ion radiation could induce the highest CRT and PDL1 expression under normoxia. However, under hypoxia, radiation could not further enhance the high baseline expression of CRT and PDL1.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] PDL1 expression in desmoplastic melanoma is associated with tumor aggressiveness and progression
    Kraft, Stefan
    Fernandez-Figueras, Maria-Teresa
    Richarz, Nina A.
    Flaherty, Keith T.
    Hoang, Mai P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (03) : 534 - 542
  • [2] Expression of PDL1 in Gastric Adenocarcinomas and Associated Tumor Infiltrating Lymphocytes
    Thompson, Elizabeth
    Abdelfatah, Eihab
    Taube, Janis
    Duncan, Mark
    Ahuja, Nita
    Kelly, Ronan
    Anders, Robert
    MODERN PATHOLOGY, 2015, 28 : 195A - 196A
  • [3] Expression of PDL1 in Gastric Adenocarcinomas and Associated Tumor Infiltrating Lymphocytes
    Thompson, Elizabeth
    Abdelfatah, Eihab
    Taube, Janis
    Duncan, Mark
    Ahuja, Nita
    Kelly, Ronan
    Anders, Robert
    LABORATORY INVESTIGATION, 2015, 95 : 195A - 196A
  • [4] Expression of PD1/PDL1 in gastric cancer at different microsatellite status and its correlation with infiltrating immune cells in the tumor microenvironment
    Wang, Yan-li
    Gong, Yuehua
    Lv, Zhi
    Li, Liang
    Yuan, Yuan
    JOURNAL OF CANCER, 2021, 12 (06): : 1698 - 1707
  • [5] A Novel Method for the Simultaneous Assessment of PDL1 Expression in the Tumor Cells and Tumor Associated Macrophages of Classical Hodgkin Lymphoma
    Carey, Chris
    Sun, Heather
    Stack, Edward
    Peterson, Michael
    Hoyt, Clifford
    Johnson, Kent
    Freeman, Gordon
    Loda, Massimo
    Shipp, Margaret
    Rodig, Scott
    Bowden, Michaela
    LABORATORY INVESTIGATION, 2015, 95 : 339A - 339A
  • [6] A Novel Method for the Simultaneous Assessment of PDL1 Expression in the Tumor Cells and Tumor Associated Macrophages of Classical Hodgkin Lymphoma
    Carey, Chris
    Sun, Heather
    Stack, Edward
    Peterson, Michael
    Hoyt, Clifford
    Johnson, Kent
    Freeman, Gordon
    Loda, Massimo
    Shipp, Margaret
    Rodig, Scott
    Bowden, Michaela
    MODERN PATHOLOGY, 2015, 28 : 339A - 339A
  • [7] Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types
    Martin-Romano, Patricia
    Castanon, Eduardo
    Ammari, Samy
    Champiat, Stephane
    Hollebecque, Antoine
    Postel-Vinay, Sophie
    Baldini, Capucine
    Varga, Andrea
    Michot, Jean Marie
    Vuagnat, Perrine
    Marabelle, Aurelien
    Soria, Jean-Charles
    Ferte, Charles
    Massard, Christophe
    CANCER MEDICINE, 2020, 9 (08): : 2643 - 2652
  • [8] Potential therapeutic target for PD1/PDL1 blockade in microsatellite medullary carcinomas based on PDL1 expression by tumor cells and infiltration by numerous PD1+T lymphocytes.
    Bossard, Celine
    Ott, Eva
    Dansette, Delphine
    Ouary, Adrien
    Bezieau, Stephane
    Toquet, Claire
    Mosnier, Jean-Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Quantitative measurement of PDL1 expression across tumor types using laser capture microdissection and reverse phase protein microarray
    Baldelli, Elisa
    Calvert, Valerie
    Hodge, K. Alex
    Sereni, Maria Isabella
    Gambara, Guido
    Haura, Eric B.
    Crino', Lucio
    Dunetz, Bryant
    Pecorelli, Sergio
    Perry, David J.
    Anthony, Stephen P.
    Robert, Nicholas
    Northfelt, Donald W.
    Jahanzeb, Mohammad
    Petricoin, Emanuel F.
    Pierobon, Mariaelena
    CANCER RESEARCH, 2017, 77
  • [10] Triple negative breast cancers: PDL1 expression in neoplastic and inflammatory cells
    Sahin, H.
    Ercetin, S. Y.
    Ugurlu, U.
    Gulluoglu, B.
    Aribal, E.
    Kaya, H.
    VIRCHOWS ARCHIV, 2017, 471 : S306 - S306